Medtronic plc
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Geoffrey Straub Martha
- Full Time Employees
- 95,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Building Two, Parkmore Business Park West Galway GA Ireland H91 4K49
- IPO Date
- May 2, 1973
- CIK
- 0001613103
- Website
- medtronic.com
- Similar Companies
- Business
- Medtronic plc (NYSE: MDT) develops, manufactures, and markets a wide range of medical devices and therapies for the treatment of chronic diseases worldwide. The company offers products across four main segments: cardiovascular (including pacemakers, defibrillators, heart valves, and coronary stents under brands such as Evera, Protecta, and CoreValve); medical surgical (featuring surgical navigation systems, endoscopic tools, and stapling devices like Hugo RAS and Valiant NaviCore); neuroscience (encompassing spinal cord stimulators, deep brain stimulation systems, and intrathecal drug delivery pumps such as Incepta and SynchroMed II); and diabetes (primarily continuous glucose monitoring systems, insulin pumps, and related software through the MiniMed and Guardian brands). Medtronic provides services including patient management software, remote monitoring platforms, and clinical decision support tools to healthcare providers, hospitals, clinics, and patients globally. Founded in 1949 and headquartered in Dublin, Ireland, with principal executive offices in Minneapolis, Minnesota, USA, Medtronic operates in more than 150 countries, serving markets in North America, Europe, Asia-Pacific, Latin America, and the Middle East through direct sales forces, distributors, and subsidiaries. The company targets physicians, hospitals, ambulatory surgery centers, and home care settings, with a focus on minimally invasive therapies and digital health solutions. Key subsidiaries include Covidien (acquired in 2015 for surgical and patient monitoring products) and Intersect ENT (recently integrated for sinus implants). In the past 1-2 years, Medtronic has pursued strategic expansions including the FDA approval and U.S. launch of the Hugo robotic-assisted surgery (RAS) system in 2024 for soft tissue indications, building on its European CE Mark; a multi-year collaboration with NVIDIA announced in 2024 to advance AI-enabled therapies using Medtronic's Gigamon data platform; and the acquisition of Mazor Robotics in 2018 followed by ongoing enhancements to its spinal robotics portfolio with the Mazor X Stealth Edition. The company completed a $4.1 billion acquisition of Covidien assets integration and reported expansions in diabetes care via the Simplera Sync sensor FDA clearance in 2024. Medtronic also announced organizational realignments in 2025 to streamline its four operating units amid portfolio optimization efforts.
Orchestra BioMed: Nearing The First Of Two Pivotal Readouts
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors
A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026
Andra AP fonden Trims Stock Holdings in Medtronic PLC $MDT
Medtronic to announce financial results for its first quarter of fiscal year 2027
Decker Wealth Management LLC Invests $5.08 Million in Medtronic PLC $MDT
Medtronic PLC $MDT Shares Sold by Allspring Global Investments Holdings LLC
Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain
Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider
Medtronic: Undervalued, And The Tailwinds Are Just Getting Started
Medtronic: Guidance Built To Be Beaten - Buy
Medtronic: A Near Decade High Dividend For This Aristocrat
3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)
Why Is Medtronic (MDT) Up 1.5% Since Last Earnings Report?
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
Is Medtronic PLC (MDT) a Bargain After 3.3% Drop? GF Value Says Undervalued
GMED vs. MDT: Which Medical Stock Has More Upside Potential?
2 High-Yield Dividend Stocks to Buy and Hold for a Decade
Is It Worth Investing in Medtronic (MDT) Based on Wall Street's Bullish Views?
This Undervalued Medical-Devices Stock Is Poised for a Rebound